Price Setting Appeals to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country's most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines, prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting…

Read Full Article »
Comment
Show comments Hide Comments

Related Articles